Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
Theme

Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

News and notifications

Danish Medicines Agency closed over Christmas and New Year

10 December 2024

2024 deadline for submitting applications concerning marketing authorisations and clinical trials

05 November 2024

Nyt lægemiddel tilføjet listen over kritiske lægemidler med forsyningsproblemer

09 December 2024

Common nordic packages for better availability

02 December 2024